Skip to main content

Incyte Corp

INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000879169

In the last 90 days, Incyte Corp insiders filed 0 open-market purchases and 10 sales; 860 institutions reported holding it in 13F filings for Q2 2026, worth $23.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Incyte Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
4 insiders, $18.2M in total
Insiders trading
4
Net value
−$18.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Incyte Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Incyte Corp
NameTitleLast reported holdingLast filingFilings, past year
Gardner David HEVP, Chief Strategy Officer15,904Sep 24, 20262
Cagnoni Pablo JPresident, Global Head of R&D183,200Sep 17, 202613
Basi Ramitpal KEVP, Human Resources10,993Aug 27, 20262
Mayes Patrick AEVP & Chief Scientific Officer61,441Aug 7, 20268
Morrissey Michael JamesEVP, Head of Tech. Operations34,065Jul 27, 20266
Heeson LeeEVP, Head of Incyte Intl38,041Jul 27, 20265
Tray ThomasPrincipal Accounting Officer21,699Jul 20, 20268
Stein Steven HCMO & Head of Late-Stage Dev.30,916Jul 20, 20269
Issa Mohamed KhairieEVP, Head of U.S. Commercial71,797Jul 20, 20264
Hoffman Richard A.EVP & General Counsel16,861Jul 20, 20262
Meury WilliamChief Executive Officer183,129Jul 20, 20263
Baker JulianDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker FelixDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker Bros. Advisors LPDirector, 10% Owner28,205,760IndirectJul 2, 20266
Baker Brothers Life Sciences LPDirector, 10% Owner28,205,760IndirectJul 2, 20266
667, L.P.Director, 10% Owner28,205,760IndirectJul 2, 20266
Baker Bros. Advisors (GP) LLCDirector, 10% Owner28,205,760IndirectJul 2, 20266
Clancy Paul JDirector25,635Jul 2, 20266
Harrigan EdmundDirector23,019Jul 2, 20265
Brawley Otis WDirector12,894Jun 10, 20261
Bienaime Jean JacquesDirector24,424Jun 10, 20262
Fouse Jacqualyn ADirector20,968Jun 10, 20261
High Katherine ADirector14,983Jun 10, 20261
Upadhyay SuketuEVP & Chief Financial Officer26,343May 6, 20261
Trotta MatteoEVP, GM, Dermatology US14,882Mar 26, 20262
Hoppenot HerveDirector326,803Dec 10, 20252
Denton Sheila A.EVP & General Counsel26,569Nov 19, 20254
Flannelly Barry PEVP & General Manager US35,149Jul 17, 20250
Iyengar Vijay KEVP, GMAPPS40,540Jul 17, 20250
Swain Paula JEVP, Human Resources106,482Jul 16, 20250
Stamoulis ChristianaEVP & Chief Financial Officer125,759Jul 16, 20250
Schaffert SusanneDirector7,389Jun 12, 20250
Dickinson Jonathan ElliottEVP, General Manager, Europe36,390Sep 16, 20240
Pasquale Maria EEVP & General Counsel69,724Jul 18, 20230
Dhanak DashyantEVP & Chief Scientific Officer58,968Jul 18, 20230
Dixon Wendy LDirector17,768Apr 4, 20220
Trower PaulPrincipal Accounting Officer32,268Jan 21, 20220
Wenqing YaoEVP, Head of Discovery Chem98,575Jul 7, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2021 (view filing)Jul 11 dayDhanak DashyantEVP & Chief Scientific OfficerSSale−396$84.09−$33.3K−1.5%26.1K after
Aug 2, 2021 (view filing)Jul 294 daysIyengar Vijay KEVP GPS, BD, & LicensingSSale−4.91K$78.29−$384.5K−15.4%27.0K after
Aug 4, 2021 (view filing)Aug 22 daysDhanak DashyantEVP & Chief Scientific OfficerSSale−389$77.49−$30.1K−1.2%32.0K after
Sep 3, 2021 (view filing)Sep 12 daysDhanak DashyantEVP & Chief Scientific OfficerSSale−388$76.71−$29.8K−1.2%31.7K after
Oct 4, 2021 (view filing)Oct 13 daysDhanak DashyantEVP & Chief Scientific OfficerSSale−389$68.67−$26.7K−1.2%31.3K after
Dec 17, 2021 (view filing)6:30 PM ETDec 15-172 daysBaker Julian and 5 othersDirector, 10% OwnerPPurchase+1.60M$72.43+$115.6M+5.4%30.9M after10 lots
Dec 27, 2021 (view filing)Dec 234 daysDixon Wendy LDirectorSSale−20.0K$22.05−$441.0K−53.7%17.3K after
Jan 5, 2022 (view filing)Jan 41 daySwain Paula JEVP, Human ResourcesSSale−9.32K$73.46−$684.6K−11.4%72.4K after
Jan 5, 2022 (view filing)Jan 32 daysTrower PaulPrincipal Accounting OfficerSSale−8.21K$73.31−$602.2K−20.3%32.3K after2 lots
Jan 11, 2022 (view filing)Jan 74 daysSwain Paula JEVP, Human ResourcesSSale−10.9K$73.31−$796.9K−13.1%72.4K after
Feb 2, 2022 (view filing)Jan 312 daysDickinson Jonathan ElliottEVP, General Manager, EuropeSSale−7.38K$74.19−$547.2K−19.6%30.2K after
Feb 14, 2022 (view filing)5:23 PM ETFeb 10-144 daysBaker Julian and 5 othersDirector, 10% OwnerPPurchase+1.60M$66.91+$107.0M+5.2%32.5M after7 lots
Feb 22, 2022 (view filing)5:45 PM ETFeb 17-225 daysBaker Julian and 5 othersDirector, 10% OwnerPPurchase+525.8K$67.96+$35.7M+1.6%33.0M after8 lots
Mar 10, 2022 (view filing)6:02 PM ETMar 8-102 daysBaker Julian and 5 othersDirector, 10% OwnerPPurchase+389.1K$72.24+$28.1M+1.2%33.4M after10 lots
Apr 12, 2022 (view filing)Apr 84 daysFlannelly Barry PEVP & General Manager USSSale−44.0K$83.49−$3.67M−40.3%65.2K after4 lots
Jul 11, 2022 (view filing)Jul 74 daysFlannelly Barry PEVP & General Manager USSSale−2.87K$79.38−$228.1K−3.8%72.7K after
Jul 11, 2022 (view filing)Jul 74 daysIyengar Vijay KEVP, GMAPPSSSale−5.79K$79.38−$459.4K−12.6%40.3K after
Jul 26, 2022 (view filing)Jul 224 daysTray ThomasPrincipal Accounting OfficerSSale−1.56K$83.13−$130.0K−8.1%17.7K after
Dec 21, 2022 (view filing)Dec 192 daysTray ThomasPrincipal Accounting OfficerSSale−1.22K$82.16−$100.5K−6.9%16.6K after
Dec 28, 2022 (view filing)Dec 235 daysIyengar Vijay KEVP, GMAPPSSSale−17.3K$80.80−$1.40M−31.4%37.9K after4 lots
Jan 6, 2023 (view filing)Jan 42 daysStein Steven HEVP & Chief Medical OfficerSSale−28.4K$79.78−$2.27M−20.7%109.0K after
Jan 30, 2023 (view filing)Jan 264 daysDhanak DashyantEVP & Chief Scientific OfficerSSale−2.42K$85.00−$205.6K−4.3%53.3K after
Jan 30, 2023 (view filing)Jan 264 daysIyengar Vijay KEVP, GMAPPSSSale−7.00K$85.00−$595.0K−14.0%42.8K after
Feb 1, 2023 (view filing)Jan 302 daysPasquale Maria EEVP & General CounselSSale−60.0K$84.74−$5.09M−46.7%68.5K after6 lots
Feb 2, 2023 (view filing)Jan 312 daysPasquale Maria EEVP & General CounselSSale−802$84.06−$67.4K−1.2%68.5K after
Aug 3, 2023 (view filing)Aug 12 daysStein Steven HEVP & Chief Medical OfficerSSale−21.5K$63.28−$1.36M−18.1%97.6K after10b5-1
Sep 6, 2023 (view filing)Sep 15 daysSwain Paula JEVP, Human ResourcesSSale−8.45K$65.13−$550.3K−9.8%77.5K after
Dec 14, 2023 (view filing)Dec 12-132 daysTray ThomasPrincipal Accounting OfficerSSale−1.28K$61.55−$78.6K−5.2%23.4K after2 lots10b5-1
Jan 4, 2024 (view filing)Jan 22 daysIyengar Vijay KEVP, GMAPPSSSale−657$65.00−$42.7K−1.5%43.4K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysStein Steven HEVP & Chief Medical OfficerSSale−7.37K$65.51−$482.5K−7.5%90.2K after10b5-1
Jun 10, 2024 (view filing)Jun 64 daysTray ThomasPrincipal Accounting OfficerSSale−1.09K$58.91−$64.4K−4.8%21.6K after10b5-1
Jun 14, 2024 (view filing)Jun 122 daysFlannelly Barry PEVP & General Manager USSSale−19.2K$60.00−$1.15M−22.4%66.4K after10b5-1
Jul 11, 2024 (view filing)Jul 92 daysFlannelly Barry PEVP & General Manager USSSale−8.15K$60.00−$488.9K−13.9%50.5K after10b5-1
Jul 17, 2024 (view filing)Jul 161 dayFlannelly Barry PEVP & General Manager USSSale−1.31K$64.19−$83.8K−2.2%58.0K after10b5-1
Jul 29, 2024 (view filing)Jul 254 daysIyengar Vijay KEVP, GMAPPSSSale−15.6K$70.00−$1.09M−29.8%36.7K after10b5-1
Aug 14, 2024 (view filing)Aug 122 daysStein Steven HEVP & Chief Medical OfficerSSale−11.6K$60.63−$703.8K−11.4%90.0K after10b5-1
Sep 16, 2024 (view filing)Sep 124 daysDickinson Jonathan ElliottEVP, General Manager, EuropeSSale−8.45K$62.36−$526.9K−18.8%36.4K after2 lots10b5-1
Sep 16, 2024 (view filing)Sep 12-134 daysTray ThomasPrincipal Accounting OfficerSSale−954$63.11−$60.2K−3.8%24.4K after2 lots10b5-1
Nov 8, 2024 (view filing)Nov 62 daysFlannelly Barry PEVP & General Manager USSSale−3.68K$79.68−$293.2K−6.0%58.0K after2 lots10b5-1
Dec 3, 2024 (view filing)Nov 294 daysIyengar Vijay KEVP, GMAPPSSSale−6.04K$75.38−$455.5K−16.5%30.7K after2 lots10b5-1
Dec 17, 2024 (view filing)Dec 13-164 daysTray ThomasPrincipal Accounting OfficerSSale−1.30K$69.98−$91.0K−5.3%23.3K after2 lots10b5-1
Jan 22, 2025 (view filing)Jan 211 dayStein Steven HEVP & Chief Medical OfficerSSale−12.4K$72.69−$897.9K−15.6%67.0K after10b5-1
Feb 28, 2025 (view filing)Feb 262 daysDenton Sheila A.EVP & General CounselSSale−14.1K$74.07−$1.04M−35.2%25.8K after2 lots10b5-1
Mar 6, 2025 (view filing)Mar 42 daysDenton Sheila A.EVP & General CounselSSale−599$69.99−$41.9K−2.3%25.8K after10b5-1
Mar 18, 2025 (view filing)Mar 144 daysFlannelly Barry PEVP & General Manager USSSale−19.8K$67.69−$1.34M−37.1%33.6K after3 lots10b5-1
Jun 3, 2025 (view filing)May 30-Jun 24 daysTray ThomasPrincipal Accounting OfficerSSale−1.61K$65.38−$105.5K−6.8%22.0K after2 lots10b5-1
Jun 5, 2025 (view filing)Jun 32 daysDenton Sheila A.EVP & General CounselSSale−1.79K$68.00−$122.1K−6.3%26.5K after10b5-1
Jul 7, 2025 (view filing)Jul 34 daysIyengar Vijay KEVP, GMAPPSSSale−8.62K$68.15−$587.3K−18.6%37.7K after2 lots10b5-1
Jul 7, 2025 (view filing)Jul 25 daysDenton Sheila A.EVP & General CounselSSale−599$68.61−$41.1K−2.2%26.5K after10b5-1
Jul 7, 2025 (view filing)Jul 34 daysFlannelly Barry PEVP & General Manager USSSale−10.9K$68.15−$743.0K−21.5%39.7K after10b5-1